Urotensin II stimulates vascular endothelial growth factor secretion from adventitial fibroblasts in synergy with angiotensin II

Circulation Journal

Volumn 76, Issue 5, 2012, Pages 1267-1273

  Song, Nana ^a   Ding, Wenhui ^a   Chu, Songyun ^a   Zhao, Jing ^a   Dong, Xiao ^a   Di, Beibing ^a   Tang, Chaoshu ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Adventitial fibroblasts; Angiotensin II; Urotensin II; Vascular endothelial growth factor; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE; UROTENSIN II; VASCULOTROPIN;

ADVENTITIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE; DRUG SYNERGISM; FIBROBLASTS; GENE EXPRESSION REGULATION; MALE; MAP KINASE SIGNALING SYSTEM; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; UROTENSINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTOR AGENTS;

EID: 84860122756     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0870     Document Type: Article

References (29)

1. Sartore S, Chiavegato A, Faffin E, Franch R, Puato M, Ausoni S, et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Cir Res 2011; 89: 1111-1121.
2. Stenmark KR, Davie N, Fird M, Gerasimovskaya E, Das M. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 2006; 21: 134-145.
3. Zhang YG, Li J, Li YG, Wei RH. Urotensin II induces phenotypic differentiation, migration and collagen synthesis of adventitial fibroblasts from rat aorta. Journal of Hypertension 2008; 26: 1119-1126.
4. Kinoshita T, Asia T. Role of rennin-angiotensin system inhibitors in patients undergoing off-pump coronary artery bypass grafting. Circ J 2010; 74: 1852-1858.
5. Rakowski E, Hassan GS, Dhanak D, Ohlstein EH, Douglas SA, Giaid A. A role for urotensin II in restenosis following balloon angioplasty. J Mol Cell Cardiol 2005; 39: 789-791.
6. Hassan GS, Douglas, SA, Ohlstein EH, Giaid A. Expression of urotensin-II in human coronary atherosclerosis. Peptides 2005; 26: 2464-2472.
7. Barker TA, Massett MP, Korshunoc VA, Mohan AM, Kennedy AJ, Berk BC. Angiotensin II type 2 receptor expression after vascular injury: Differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blocker. Hypertension 2006; 48: 942-949.
8. Albertin G, Guidolin D, Sorato E, Spinazzi R, Mascarin A, Oselladore B, et al. Pro-angiogenic activity of urotensin-II on different human vascular endothelial cell populations. Regul Pept 2009; 157: 64-71.
9. Iglewski M, Grant SR. Urotensin II-induced signaling involved in proliferation vascular smooth muscle cells. Vasc Health Risk Manag 2010; 6: 723-734.
10. Pan P, Fu H, Zhang L, Huang H, Luo F, Wu W, et al. Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol 2010; 26: 36.
11. Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao YN, Imamura T, et al. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats. Cardiovasc Res 2005; 65: 921-929.
12. Matsui K, Yoshioka T, Murakami Y, Takahashi M, Shimada K, Ikeda U. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease. Circ J 2003; 67: 660-662.
13. Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H, et al. Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J 2004; 68: 488-493.
14. Eisenreich A, Boltzen U, Malz R, Schultheiss HP, Rauch U. Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells. Circ J 2011; 75: 1235-1242.
15. Yamamizu K, Yamashita JK. Roles of cyclic adenosine monophosphate signaling in endothelial cell differentiation and arterial-venous specification during vascular development. Circ J 2011; 75: 253-260.
16. Shin S, Lee SH, Park S, Kang SM, Chung N, Shim WH, et al. Soluble fms-like tyrosine kinase-1 and the progression of carotid intimamedia thickness: 24-month follow-up study. Circ J 2010; 74: 2211-2215.
17. Jin X, Ge X, Zhu DL, Yan C, Chu YF, Chen WD, et al. Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts. J Mol Cell Cardiol 2007; 43: 292-300.
18. Chen S, Lee JS, Wang A, Izduierdo-Lahuerta A, Gandhi NK, Danesh FR, et al. Angiotensin II stimulates alpha3 collagen production in mouse podocytes via TGF-beta and VEGF signaling: Implications for diabetic glomerulopathy. Nephrol Dial Transplant 2005; 20: 1320-1328.
19. Albertin G, Guidolin D, Sorato E, Spinazzi R, Mascarin A, Oselladore B, et al. Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations. Regulatory Peptides 2009; 157: 64-71.
20. Tsuruda T, Kato J, Cao YN, Hatakeyama K, Masuyama H, Imamura T. Adrenomedullin induces matrix metalloproteinase-2 activity in rat aortic adventitial fibroblasts. Biochem Biophys Res Commun 2004; 325: 80-84.
21. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1998; 1401: 187-194.
22. Chintalgattu V, Nair DM, Katwa LC. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 2003; 35: 277-286.
23. Botero TM, Son JS, Vodopyanov D, Hasegawa M, Shelburne CE. MAPK signaling is required for LPS-induced VEGF in pulp stem cells. J Dent Res 2010; 89: 2644-2649.
24. Markel TA, Crisostomo R, Wang M, Herring CM. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: The roles of p38, ERK, and JNK MAPK signaling. Am J Physiol Gastrointest Live Physiol 2007; 292: G958-G963.
25. Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, et al. Role of P13K/Akt and MEK/ERK in mediating Hypoxia-induced expression of HIF-α and VEGF in Laser-induced rat choroidal neovascularisation. Invest Ophthalmol Vis Sci 2009; 50: 1873-1879.
26. Bian ZM, Elner SG, Elner VM. Thrombin induces VEGF expression in human retinal pigment epithelia cells. Invest Ophthalmol Vis Sci 2007; 48: 2738-2746.
27. Wu H, Xia X, Jiang C, Wu J, Zhang S, Zheng Z, et al. High glucose attenuates insulin-induced VEGF expression in bovine retinal microvascular endothelial cells. Eye 2010; 24: 145-151.
28. Wang YX, Ding YJ, Zhu YZ, Shi Y, Yao T, Zhu YC. Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. Am J Physilo Heart Circ Physiol 2007; 292: H348-H359.
29. Lamarre NS, Tallarida RJ. A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. Eur J Pharmacol 2008; 586: 350-351.